Dawn J Caster Selected Research

Creatinine

8/2022	Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis.
7/2022	Quantitative Mass Spectrometry Normalization in Urine Biomarker Analysis in Nephrotic Syndrome.
5/2022	Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dawn J Caster Research Topics

Disease

13	Lupus Nephritis 10/2023 - 11/2013
6	Inflammation (Inflammations) 02/2022 - 08/2017
5	Proteinuria 07/2023 - 12/2017
4	Kidney Diseases (Kidney Disease) 10/2023 - 01/2019
3	Infections 01/2023 - 01/2021
3	Glomerulonephritis 01/2018 - 12/2015
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2023 - 01/2020
2	Nephritis 01/2019 - 12/2017
1	Chronic Renal Insufficiency 09/2023
1	Hypertension (High Blood Pressure) 07/2023
1	Epilepsy (Aura) 01/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2022
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 05/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Necrosis 10/2020
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2019
1	Neoplasms (Cancer) 01/2017
1	Tick-Borne Diseases (Tick-Borne Disease) 11/2014
1	Autoimmune Diseases (Autoimmune Disease) 11/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2015
4	Biomarkers (Surrogate Marker)IBA 07/2022 - 11/2018
3	voclosporinIBA 07/2023 - 01/2021
3	CreatinineIBA 08/2022 - 05/2022
2	AntigensIBA 01/2023 - 02/2021
2	Calcineurin InhibitorsIBA 01/2023 - 01/2021
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2021 - 02/2021
2	AutoantibodiesIBA 02/2021 - 12/2015
2	CytokinesIBA 10/2020 - 08/2017
2	ChemokinesIBA 10/2020 - 08/2017
1	Edetic Acid (EDTA)FDA Link 10/2023
1	Sodium-Glucose Transport ProteinsIBA 09/2023
1	GlucocorticoidsIBA 01/2023
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2023
1	SubtilisinIBA 01/2023
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2022
1	Interferon-gamma (Interferon, gamma)IBA 06/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2022
1	Angiotensin Receptor AntagonistsIBA 05/2022
1	NF-E2 Transcription FactorIBA 02/2022
1	Antiviral Agents (Antivirals)IBA 08/2021
1	moesinIBA 02/2021
1	CollagenIBA 01/2021
1	Cathepsin CIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Annexin A3IBA 01/2020
1	Cathepsin BIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 12/2017
1	UbiquitinIBA 12/2017
1	Annexin A2 (Annexin II)IBA 12/2015
1	Immunoglobulin M (IgM)IBA 11/2014
1	Immunoglobulin G (IgG)IBA 11/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2013
1	Mitogen-Activated Protein KinasesIBA 11/2013

Therapy/Procedure

5	Therapeutics 10/2023 - 08/2021
2	Transplantation 12/2017 - 01/2017
1	Precision Medicine 11/2018
1	Nephrectomy 01/2017